Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study

INTRODUCTION: The standard of care for pediatric growth hormone deficiency (pGHD) is once-daily recombinant human growth hormone (rhGH). Somatrogon, a long-acting rhGH, requires less frequent, once-weekly, dosing. We describe physicians’ preference for, experiences, and satisfaction with once-weekly...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Roy, Lamoureux, Roger, Turner-Bowker, Diane M., Loftus, Jane, Maghnie, Mohamad, Miller, Bradley S., Polak, Michel, Yaworsky, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634585/
https://www.ncbi.nlm.nih.gov/pubmed/37955005
http://dx.doi.org/10.3389/fendo.2023.1254424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634585/
https://www.ncbi.nlm.nih.gov/pubmed/37955005
http://dx.doi.org/10.3389/fendo.2023.1254424

Ejemplares similares